Ligand Pharmaceuticals Incorporated (LGND) vs Oruka Therapeutics, Inc. (ORKA)
Ligand Pharmaceuticals Incorporated and Oruka Therapeutics, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Oruka Therapeutics, Inc. are of similar size ($6.1B and $5.7B). Oruka Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs −40.2%). Across the 14 metrics below, Ligand Pharmaceuticals Incorporated leads on 11 and Oruka Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | LGND | ORKA | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.43% | 0.00% | 65.16% |
| Operating margin | 32.61% | 0.00% | 0.00% |
| Net margin | 67.88% | 0.00% | 0.00% |
| Free cash flow margin | 49.34% | 0.00% | 0.00% |
| Return on equity | 21.96% | (18.30%) | (57.72%) |
| Return on assets | 12.58% | (17.76%) | (49.22%) |
| Return on invested capital | 8.19% | (40.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack